Mobile menu icon
Mobile menu icon Search iconSearch
Search type
Illustration of a painful wrist

For participants

The BSRBR-RA is one of the largest studies in the world looking at the long-term safety of new drugs prescribed for rheumatoid arthritis in the real world. It has been capturing data since 2001 and we have now registered over 30,000 participants in the study.

We are different from a clinical trial, as we do not influence the treatment participants receive, but rather watch what happens when participants take the treatment that is prescribed by consultant rheumatologists.

Although these treatments are fully licensed and prescribed by the NHS, there is still a need to monitor their impact in the long term, which is the main role of the BSRBR-RA.